Product NDC: | 60505-2741 |
Proprietary Name: | Verapamil |
Non Proprietary Name: | Verapamil hydrochloride |
Active Ingredient(s): | 180 mg/1 & nbsp; Verapamil hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60505-2741 |
Labeler Name: | Apotex Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA200878 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121119 |
Package NDC: | 60505-2741-5 |
Package Description: | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (60505-2741-5) |
NDC Code | 60505-2741-5 |
Proprietary Name | Verapamil |
Package Description | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (60505-2741-5) |
Product NDC | 60505-2741 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Verapamil hydrochloride |
Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20121119 |
Marketing Category Name | ANDA |
Labeler Name | Apotex Corp. |
Substance Name | VERAPAMIL HYDROCHLORIDE |
Strength Number | 180 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC] |